Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Avalanche Biotechnologies, Inc. | 160,000 | reported | 15 Feb 2018 | tx 3+523,000 |
| IOVANCE BIOTHERAPEUTICS, INC. | 67,546 | reported | 13 Jun 2025 | tx 8+375,008 |
| Cardiff Oncology, Inc. | 46,019 | reported | 20 Jun 2019 | tx 2+99,056 |
| HALOZYME THERAPEUTICS, INC. | 45,568 | reported | 22 Feb 2017 | tx 20+659,445−55,865 |
| BIOMARIN PHARMACEUTICAL INC | 13,550 | reported | 20 May 2025 | tx 3+13,550 |
| Passage BIO, Inc. | 10,539 | reported | 19 May 2026 | tx 9+377,743 |
| Turning Point Therapeutics, Inc. | 0 | reported | 17 Aug 2022 | tx 39+823,304−2,272,124 |
| AMBIT BIOSCIENCES CORP | 0 | reported | 10 Nov 2014 | tx 7+140,363−241,008 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | GRANT_AWARD | Passage BIO, Inc. | 10,539 | 0.00 USD | deriv |
| 13 Jun 2025 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 67,546 | 0.00 USD | deriv |
| 28 May 2025 | GRANT_AWARD | Passage BIO, Inc. | 201,857 | 0.00 USD | deriv |
| 20 May 2025 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 6,650 | 0.00 USD | |
| 11 Jun 2024 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 49,303 | 0.00 USD | deriv |
| 21 May 2024 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 4,720 | 0.00 USD | |
| 21 May 2024 | GRANT_AWARD | Passage BIO, Inc. | 47,693 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 50,000 | 0.00 USD | deriv |
| 27 Dec 2023 | GRANT_AWARD | BIOMARIN PHARMACEUTICAL INC | 2,180 | 0.00 USD | |
| 06 Jun 2023 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 51,955 | 0.00 USD | deriv |
| 25 May 2023 | GRANT_AWARD | Passage BIO, Inc. | 24,000 | 0.00 USD | deriv |
| 17 Aug 2022 | OTHER | Turning Point Therapeutics, Inc. | 110,959 | 76.00 USD | |
| 17 Aug 2022 | OTHER | Turning Point Therapeutics, Inc. | 101,775 | — | deriv |
| 17 Aug 2022 | OTHER | Turning Point Therapeutics, Inc. | 224,640 | — | deriv |
| 17 Aug 2022 | OTHER | Turning Point Therapeutics, Inc. | 67,575 | — | deriv |
| 17 Aug 2022 | OTHER | Turning Point Therapeutics, Inc. | 325,000 | — | deriv |
| 17 Aug 2022 | OTHER | Turning Point Therapeutics, Inc. | 173,389 | — | deriv |
| 17 Aug 2022 | OTHER | Turning Point Therapeutics, Inc. | 989,971 | — | deriv |
| 17 Aug 2022 | OTHER | Turning Point Therapeutics, Inc. | 155,844 | — | deriv |
| 10 Jun 2022 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 51,204 | 0.00 USD | deriv |
| 26 May 2022 | GRANT_AWARD | Passage BIO, Inc. | 24,000 | 0.00 USD | deriv |
| 09 Feb 2022 | SALE | Turning Point Therapeutics, Inc. | 2,971 | 36.30 USD | |
| 09 Feb 2022 | GRANT_AWARD | Turning Point Therapeutics, Inc. | 62,400 | 0.00 USD | |
| 09 Feb 2022 | GRANT_AWARD | Turning Point Therapeutics, Inc. | 224,640 | 0.00 USD | deriv |
| 29 Jun 2021 | GRANT_AWARD | IOVANCE BIOTHERAPEUTICS, INC. | 35,000 | 0.00 USD | deriv |